Right, so pretty much all you need to know about Monday is that Chinese equities did one thing and everybody else did something different. US markets were quiet. The VIX is still hovering below 10 as the fleeting spike surrounding
July 17, 2017
The stock market had an amazing week as optimism surrounding earnings season pushed stocks higher. Investors are ignoring the nonsense in Washington because it’s mostly hot air. The fact that there disfunction in Washington instead of it easily passing bad
July 31, 2017, concludes the 180-day lock-up period on Invitation Homes (NYSE:INVH). When the lock-up period ends, its executives, directors and pre-IPO shareholders will have the chance to sell 225M shares, previously restricted since the firm’s IPO. (S-1/A) The possibility
Video length: 00:13:33 A slow trading day ahead of earnings season. In tonight’s video, we explore the specific strategies of trading options around earnings announcements. What are the opportunities and how you can limit your risk? Watch this crucial video
The rally in stocks continues to be unstoppable while people like me continue to bite their nails and worry. The short-term uptrend is being confirmed by the bullish percents. Junk bonds also continue to confirm the uptrend. The cumulative net
One month ago, we reported that based on recent data, June oil output from shale producers would post the first double-digit production growth since July of 2015, when oil prices tumbled and a substantial portion of US production was briefly taken offline. While
One month ago, we reported that based on recent data, June oil output from shale producers would post the first double-digit production growth since July of 2015, when oil prices tumbled and a substantial portion of US production was briefly taken offline. While
This is major stock market news: emerging stock markets are breaking out. We wrote at least once per month, since April 2016, that EEM ETF (representing emerging market stocks) should break above 42 points in order to be in a
Shares of Intercept Pharmaceuticals (ICPT) are sliding after H.C. Wainwright analyst Ed Arce raised his price target for its competitor CymaBay Therapeutics (CBAY) following data from the company’s Phase 2 study of seladelpar in primary biliary cholangitis. The analyst argued
The yearly growth rate of average hourly earnings in production and non-supervisory employment in the private sector eased to 2.3% in June from 2.4% in May. Many experts are puzzled by the subdued increase in workers earnings. After all, it
